Ye Zeng

4.9k total citations · 1 hit paper
144 papers, 3.6k citations indexed

About

Ye Zeng is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Ye Zeng has authored 144 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 41 papers in Oncology and 39 papers in Cancer Research. Recurrent topics in Ye Zeng's work include Neuroendocrine Tumor Research Advances (18 papers), Pancreatic and Hepatic Oncology Research (16 papers) and MicroRNA in disease regulation (16 papers). Ye Zeng is often cited by papers focused on Neuroendocrine Tumor Research Advances (18 papers), Pancreatic and Hepatic Oncology Research (16 papers) and MicroRNA in disease regulation (16 papers). Ye Zeng collaborates with scholars based in China, United States and Hong Kong. Ye Zeng's co-authors include John M. Tarbell, Bingmei M. Fu, Xiaoheng Liu, Xiaowu Xu, Shunrong Ji, Yi Qin, Xianjun Yu, Xinghong Yao, Qifeng Zhuo and R. H. Adamson and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Cancer Research.

In The Last Decade

Ye Zeng

134 papers receiving 3.6k citations

Hit Papers

Lactate‐induced protein lactylation: A bridge between epi... 2023 2026 2024 2025 2023 25 50 75 100

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ye Zeng China 33 1.9k 1.3k 632 550 485 144 3.6k
Nicole C. Kaneider Austria 36 1.1k 0.6× 393 0.3× 330 0.5× 202 0.4× 246 0.5× 62 3.2k
Bruce A. Hug United States 23 1.6k 0.8× 291 0.2× 433 0.7× 301 0.5× 166 0.3× 47 3.6k
Maria Felice Brizzi Italy 45 3.4k 1.8× 1.5k 1.2× 787 1.2× 300 0.5× 261 0.5× 142 5.8k
Filio Billia Canada 35 2.4k 1.2× 742 0.6× 626 1.0× 227 0.4× 264 0.5× 158 5.2k
Jian Pan China 29 1.3k 0.7× 461 0.4× 427 0.7× 312 0.6× 156 0.3× 140 2.3k
Xin Xu China 37 2.3k 1.2× 1.2k 0.9× 568 0.9× 933 1.7× 108 0.2× 124 4.1k
Michael J. Edwards United States 30 1.1k 0.6× 1.4k 1.1× 504 0.8× 236 0.4× 126 0.3× 68 3.1k
Mihael Vucur Germany 28 1.8k 0.9× 1.3k 1.0× 397 0.6× 245 0.4× 218 0.4× 74 3.8k
Bing Cui China 35 2.5k 1.3× 682 0.5× 1.0k 1.6× 612 1.1× 509 1.0× 122 4.4k

Countries citing papers authored by Ye Zeng

Since Specialization
Citations

This map shows the geographic impact of Ye Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ye Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ye Zeng more than expected).

Fields of papers citing papers by Ye Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ye Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ye Zeng. The network helps show where Ye Zeng may publish in the future.

Co-authorship network of co-authors of Ye Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Ye Zeng. A scholar is included among the top collaborators of Ye Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ye Zeng. Ye Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Yili, et al.. (2025). Endothelial cytoskeleton in mechanotransduction and vascular diseases. Journal of Biomechanics. 182. 112579–112579. 2 indexed citations
2.
Yao, Xinghong, Min Tang, Liang Li, & Ye Zeng. (2025). Role of S1PR1 in VEGF-exosomes mediated resistance of hepatocellular carcinoma to anti-angiogenesis therapy. Cancer Cell International. 25(1). 264–264. 1 indexed citations
3.
Jia, Yuming, Ye Zeng, Xin Wang, et al.. (2024). <italic>NCOA6</italic> knockdown enhances RSL3-induced ferroptosis in pancreatic cancer cells and increases the sensitivity to gemcitabine. Acta Biochimica et Biophysica Sinica. 57(8). 1260–1269. 2 indexed citations
4.
Zeng, Ye, Qiang Li, Wuhu Zhang, et al.. (2024). The stromal microenvironment endows pancreatic neuroendocrine tumors with spatially specific invasive and metastatic phenotypes. Cancer Letters. 588. 216769–216769. 9 indexed citations
5.
He, Xueling, et al.. (2024). Advances in micropillar arrays in cellular biomechanics detection and tissue engineering. Biocell. 48(11). 1521–1529. 1 indexed citations
6.
Wang, Ting, Yi Qin, Ye Zeng, et al.. (2023). A new glance at autophagolysosomal-dependent or -independent function of transcriptional factor EB in human cancer. Acta Pharmacologica Sinica. 44(8). 1536–1548. 12 indexed citations
7.
Zeng, Ye, Zheng Li, Guixiong Fan, et al.. (2023). Lactate‐induced protein lactylation: A bridge between epigenetics and metabolic reprogramming in cancer. Cell Proliferation. 56(10). e13478–e13478. 107 indexed citations breakdown →
8.
Zhan, Ying, Zi Yan, Zhi Hong Wan, et al.. (2023). Effects of online peer assessment on higher‐order thinking: A meta‐analysis. British Journal of Educational Technology. 54(4). 817–835. 30 indexed citations
9.
Wan, Feng, et al.. (2023). Modulation of muscarinic receptors by anisodine hydrobromide in cerebral ischemia. Cellular and Molecular Biology. 69(11). 17–24.
10.
Xu, Xiaowu, Ye Zeng, Xin Lou, et al.. (2022). Role of Somatostatin Receptor 2 in Nonfunctional Pancreatic Neuroendocrine Tumors. Pancreas. 51(10). 1404–1410. 3 indexed citations
11.
Zhong, Rui, et al.. (2021). The effectiveness and safety of Sun tip-flexible ureterorenoscope for the management of kidney stones. Medicine. 100(1). e23964–e23964. 3 indexed citations
12.
Zeng, Zhu, Yong Zhao, Shuai Zhu, et al.. (2021). Hypoxic exosomal HIF-1α-stabilizing circZNF91 promotes chemoresistance of normoxic pancreatic cancer cells via enhancing glycolysis. Oncogene. 40(36). 5505–5517. 118 indexed citations
13.
Zeng, Ye, Yi Qin, Xiaowu Xu, et al.. (2021). Mutations in key driver genes of pancreatic cancer: molecularly targeted therapies and other clinical implications. Acta Pharmacologica Sinica. 42(11). 1725–1741. 100 indexed citations
14.
Sun, Qiqing, Yiyin Zhang, Mengqi Liu, et al.. (2019). Prognostic and diagnostic significance of galectins in pancreatic cancer: a systematic review and meta-analysis. Cancer Cell International. 19(1). 309–309. 20 indexed citations
15.
Deng, Shi-Jiang, Hengyu Chen, Zhu Zeng, et al.. (2018). Nutrient Stress–Dysregulated Antisense lncRNA GLS-AS Impairs GLS-Mediated Metabolism and Represses Pancreatic Cancer Progression. Cancer Research. 79(7). 1398–1412. 103 indexed citations
16.
Niu, Yi, Yan Jin, Shichang Deng, et al.. (2018). MiRNA-646-mediated reciprocal repression between HIF-1α and MIIP contributes to tumorigenesis of pancreatic cancer. Oncogene. 37(13). 1743–1758. 46 indexed citations
17.
Zeng, Ye, et al.. (2017). Mechanical microenvironment regulation of age-related diseases involving degeneration of human skeletal and cardiovascular systems. Progress in Biophysics and Molecular Biology. 148. 54–59. 13 indexed citations
18.
Zeng, Ye, Eno E. Ebong, Bingmei M. Fu, & John M. Tarbell. (2012). The Structural Stability of the Endothelial Glycocalyx after Enzymatic Removal of Glycosaminoglycans. PLoS ONE. 7(8). e43168–e43168. 105 indexed citations
19.
Zeng, Ye, et al.. (2012). Numerical simulation of the effect of permeability on the hydrodynamics in a parallel-plate coculture flow chamber. Computer Methods in Biomechanics & Biomedical Engineering. 17(8). 875–887. 3 indexed citations
20.
Zeng, Ye, Chang Yu, Yi Lai, et al.. (2010). CXCR1 and CXCR2 are novel mechano-sensors mediating laminar shear stress-induced endothelial cell migration. Cytokine. 53(1). 42–51. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026